X-Linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase.

Chronic granulomatous disease (CGD) is a hereditary disorder of host defense due to absent or decreased activity of phagocyte NADPH oxidase. The X-linked form of the disease derives from defects in the CYBB gene, which encodes the 91-kD glycoprotein component (termed "gp91-phox") of the oxidase. We have identified the mutations in the CYBB gene responsible for X-linked CGD in 131 consecutive independent kindreds. Screening by SSCP analysis identified mutations in 124 of the kindreds, and sequencing of all exons and intron boundary regions revealed the other seven mutations. We detected 103 different specific mutations; no single mutation appeared in more than seven independent kindreds. The types of mutations included large and small deletions (11%), frameshifts (24%), nonsense mutations (23%), missense mutations (23%), splice-region mutations (17%), and regulatory-region mutations (2%). The distribution of mutations within the CYBB gene exhibited great heterogeneity, with no apparent mutational hot spots. Evaluation of 87 available mothers revealed X-linked carrier status in all but 10. The heterogeneity of mutations and the lack of any predominant genotype indicate that the disease represents many different mutational events, without a founder effect, as is expected for a disorder with a previously lethal phenotype.

[1]  M. Dinauer,et al.  Biosynthesis of the phagocyte NADPH oxidase cytochrome b558. Role of heme incorporation and heterodimer formation in maturation and stability of gp91phox and p22phox subunits. , 1997, The Journal of biological chemistry.

[2]  R. Mazzarella,et al.  X chromosome map at 75-kb STS resolution, revealing extremes of recombination and GC content. , 1997, Genome research.

[3]  A. Segal,et al.  Analysis of glycosylation sites on gp91phox, the flavocytochrome of the NADPH oxidase, by site-directed mutagenesis and translation in vitro. , 1997, The Biochemical journal.

[4]  F. DeLeo,et al.  Assembly of the phagocyte NADPH oxidase: molecular interaction of oxidase proteins , 1996, Journal of leukocyte biology.

[5]  D. Roos,et al.  Interactions between the components of the human NADPH oxidase: intrigues in the phox family. , 1996, The Journal of laboratory and clinical medicine.

[6]  D. Roos X-CGDbase: a database of X-CGD-causing mutations. , 1996, Immunology today.

[7]  L. Chasin,et al.  Phosphoribosyltransferase Rna. Cytoplasmic Adenine Effects of Nonsense Mutations on Nuclear And , 1995 .

[8]  C. Meischl,et al.  Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. , 1996, Blood.

[9]  A. Segal,et al.  Molecular analysis in three cases of X91- variant chronic granulomatous disease. , 1995, Blood.

[10]  A. Cross,et al.  Cytochrome b-245 of the neutrophil superoxide-generating system contains two nonidentical hemes. Potentiometric studies of a mutant form of gp91phox. , 1995, The Journal of biological chemistry.

[11]  Algirdas J. Jesaitis,et al.  Topological Mapping of Neutrophil Cytochrome b Epitopes with Phage-display Libraries (*) , 1995, The Journal of Biological Chemistry.

[12]  L. Maquat When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells. , 1995, RNA.

[13]  T. Suzutani,et al.  A new mutation in exon 12 of the gp91-phox gene leading to cytochrome b-positive X-linked chronic granulomatous disease. , 1995, Blood.

[14]  D. Skalnik,et al.  Characterization of a gp91-phox Promoter Element That Is Required for Interferon γ-induced Transcription (*) , 1995, The Journal of Biological Chemistry.

[15]  P. Newburger,et al.  A new X-linked variant of chronic granulomatous disease characterized by the existence of a normal clone of respiratory burst-competent phagocytic cells. , 1995, Blood.

[16]  P. Newburger,et al.  Chronic granulomatous disease and glutathione peroxidase deficiency, revisited. , 1994, Blood.

[17]  P. Newburger,et al.  Mutations in the promoter region of the gene for gp91-phox in X-linked chronic granulomatous disease with decreased expression of cytochrome b558. , 1994, The Journal of clinical investigation.

[18]  H. Ochs,et al.  A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox. , 1994, The Journal of clinical investigation.

[19]  I. Matsuda,et al.  Homologous dinucleotide (GT or TG) deletion in Japanese patients with chronic granulomatous disease with p47-phox deficiency. , 1994, Biochemical and biophysical research communications.

[20]  T. Ariga,et al.  Molecular genetic studies of two families with X‐linked chronic granulomatous disease: Mutation analysis and definitive determination of carrier status in patients' sisters , 1994, European journal of haematology.

[21]  J. Palmblad,et al.  A 40‐base‐pair duplication in the gp91‐phox gene leading to X‐linked chronic granulomatous disease , 1993, European journal of haematology.

[22]  L. Chasin,et al.  Splicing mutants and their second-site suppressors at the dihydrofolate reductase locus in Chinese hamster ovary cells , 1993, Molecular and cellular biology.

[23]  W. Marsh,et al.  The Kell blood group system and the McLeod phenotype. , 1993, Seminars in hematology.

[24]  J. Curnutte Chronic granulomatous disease: the solving of a clinical riddle at the molecular level. , 1993, Clinical immunology and immunopathology.

[25]  Y. Lin,et al.  In vitro molecular reconstitution of the respiratory burst in B lymphoblasts from p47-phox-deficient chronic granulomatous disease. , 1993, The Journal of clinical investigation.

[26]  A. Segal,et al.  Cytochrome b-245 is a flavocytochrome containing FAD and the NADPH-binding site of the microbicidal oxidase of phagocytes. , 1992, The Biochemical journal.

[27]  H. Ochiai,et al.  Topology of cytochrome b558 in neutrophil membrane analyzed by anti-peptide antibodies and proteolysis. , 1992, The Journal of biological chemistry.

[28]  S. Orkin,et al.  Splice site mutations are a common cause of X-linked chronic granulomatous disease. , 1992, Blood.

[29]  P. Newburger,et al.  Chronic granulomatous disease presenting in a 69-year-old man. , 1991, The New England journal of medicine.

[30]  S. Orkin,et al.  CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter. , 1991, The Journal of biological chemistry.

[31]  A. de Klein,et al.  Point mutations in the beta-subunit of cytochrome b558 leading to X-linked chronic granulomatous disease. , 1991, Blood.

[32]  D. Bentley,et al.  Autosomal recessive chronic granulomatous disease caused by deletion at a dinucleotide repeat. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[33]  S. Orkin,et al.  Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. , 1990, The Journal of clinical investigation.

[34]  R. Levinsky,et al.  Prognosis of chronic granulomatous disease. , 1990, Archives of disease in childhood.

[35]  H. Malech,et al.  Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src. , 1990, Science.

[36]  S. Orkin,et al.  A missense mutation in the neutrophil cytochrome b heavy chain in cytochrome-positive X-linked chronic granulomatous disease. , 1989, The Journal of clinical investigation.

[37]  T. Sekiya,et al.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. , 1989, Genomics.

[38]  A. Fischer,et al.  Incidence, severity, and prevention of infections in chronic granulomatous disease. , 1989, The Journal of pediatrics.

[39]  T. Sekiya,et al.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[40]  S. Orkin,et al.  Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma. , 1989, The New England journal of medicine.

[41]  D. Rotrosen,et al.  Two forms of autosomal chronic granulomatous disease lack distinct neutrophil cytosol factors. , 1988, Science.

[42]  W. Nauseef,et al.  Two cytosolic neutrophil oxidase components absent in autosomal chronic granulomatous disease. , 1988, Science.

[43]  R. Johnston,et al.  Clinical features and current management of chronic granulomatous disease. , 1988, Hematology/oncology clinics of North America.

[44]  J. Curnutte Classification of chronic granulomatous disease. , 1988, Hematology/oncology clinics of North America.

[45]  S. Orkin,et al.  Primary structure and unique expression of the 22-kilodalton light chain of human neutrophil cytochrome b. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[46]  S. Antonarakis,et al.  Nonsense and missense mutations in hemophilia A: estimate of the relative mutation rate at CG dinucleotides. , 1988, American journal of human genetics.

[47]  S. Orkin,et al.  Gene deletion in a patient with chronic granulomatous disease and McLeod syndrome: fine mapping of the Xk gene locus. , 1988, Blood.

[48]  S. Orkin,et al.  Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease. , 1987, The Journal of clinical investigation.

[49]  J. Curnutte,et al.  Activation of neutrophil NADPH oxidase in a cell-free system. Partial purification of components and characterization of the activation process. , 1987, The Journal of biological chemistry.

[50]  G. Stamatoyannopoulos,et al.  The molecular basis of blood diseases , 1987 .

[51]  Tom Maniatis,et al.  A role for exon sequences and splice-site proximity in splice-site selection , 1986, Cell.

[52]  A. Monaco,et al.  Cloning the gene for an inherited human disorder—chronic granulomatous disease—on the basis of its chromosomal location , 1986, Nature.

[53]  J. Haines,et al.  DNA linkage analysis of X chromosome-linked chronic granulomatous disease. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[54]  A. Monaco,et al.  Cloning the gene for the inherited disorder chronic granulomatous disease on the basis of its chromosomal location. , 1986, Cold Spring Harbor symposia on quantitative biology.

[55]  S. Latt,et al.  Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization. , 1985, Science.

[56]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[57]  A. Segal,et al.  Absence of cytochrome b-245 in chronic granulomatous disease. A multicenter European evaluation of its incidence and relevance. , 1983, The New England journal of medicine.

[58]  P. Densen,et al.  Kx: its relationship to chronic granulomatous disease and genetic linkage with Xg. , 1981, Blood.

[59]  K. Lange,et al.  Effects of reproductive compensation and genetic drift on X-linked lethals. , 1978, American journal of human genetics.

[60]  Schraibman Ig,et al.  Letter: Intravenous regional sympathetic block with guanethidine. , 1974 .

[61]  R. Good,et al.  Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function. , 1966, Lancet.

[62]  R. Good,et al.  A fatal granulomatous disease of childhood; the clinical, pathological, and laboratory features of a new syndrome. , 1959, A.M.A. journal of diseases of children.

[63]  R. Good,et al.  A fatal granulomatosus of childhood: the clinical study of a new syndrome. , 1957, Minnesota medicine.